DNMT1 and non-small cell lung carcinoma: Sui et al. [25] reported that miR-148b is substantially downregulated in cisplatin-resistant NSCLC cells, and that upregulation of miR-148b can increase the sensitivity to cisplatin by negatively regulating DNMT1 expression.